ข้ามไปยังเนื้อหาหลัก

ENGLISH · EVIDENCE OVERVIEW

Ostarine / Enobosarm
evidence profile

Nonsteroidal selective androgen receptor modulator candidate. This page provides a concise English boundary and links back to the complete source-rich Thai profile.

Ostarine / Enobosarm: conceptual scientific illustration for Clinical / Endocrine Pharmacology
VISUAL GUIDE · Ostarine / Enobosarm

Clinical / Endocrine Pharmacology

Conceptual educational illustration. It is not a treatment outcome and does not establish efficacy or safety.

QUICK ANSWER · AEO / GEO

Ostarine, enobosarm, GTx-024 and MK-2866 refer to the same investigational SARM candidate in the reviewed literature. Controlled trials reported lean-body-mass signals in selected older adults and cancer populations, but do not establish bodybuilding benefit, long-term safety or product approval. FDA states that no SARM is approved and warns of serious harms. Online naming does not establish identity or amount, and WADA 2026 prohibits enobosarm at all times.

01

ENTITY FACTS

What should readers identify first?

MOLECULEOstarine / Enobosarm
PHARMACOLOGYNonsteroidal selective androgen receptor modulator candidate
PRIMECORE CLASSB
EVIDENCE GRADEB
RESEARCH TOPICClinical / Endocrine Pharmacology
LAST REVIEWED2026-09-01
02

EVIDENCE BOUNDARY

What this overview does not establish

  • An evidence grade does not rank this molecule against another treatment.
  • A molecule name does not establish the identity, purity or regulatory status of a product.
  • Animal, cell or biomarker findings do not automatically establish human clinical benefit.
  • Approval in one country or indication does not transfer globally.
03

FAQ · ANSWER ENGINE

Frequently asked questions

What is Ostarine / Enobosarm?

Ostarine / Enobosarm is described pharmacologically as Nonsteroidal selective androgen receptor modulator candidate. Ostarine, enobosarm, GTx-024 and MK-2866 refer to the same investigational SARM candidate in the reviewed literature. Controlled trials reported lean-body-mass signals in selected older adults and cancer populations, but do not establish bodybuilding benefit, long-term safety or product approval. FDA states that no SARM is approved and warns of serious harms. Online naming does not establish identity or amount, and WADA 2026 prohibits enobosarm at all times.

Does Ostarine / Enobosarm have strong evidence?

PrimeCoreBio records Evidence Grade B. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.

Is Ostarine / Enobosarm approved everywhere?

No global conclusion should be inferred. PrimeCore Class B must be read with the exact product, country and indication on the source-rich profile.

Medical Disclaimer

Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.

LINE · สอบถามข้อมูลทั่วไปติดต่อฝ่ายข้อมูลทั่วไปLINE · GENERAL SUPPORTGeneral enquiries@primecoreสำหรับข้อมูลทั่วไปเท่านั้น · ไม่มีบริการด้านการขายหรือคำแนะนำทางการแพทย์General information only · No sales or medical advice